NCT01373645

Safety and Efficacy Registry of Yinyi Stent

Safety and Efficacy Registry of Yinyi Polymer-free Paclitaxel-eluting Stent

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 1,045 (actual)
• Sponsor: Shanghai Jiao Tong University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Drug-eluting stents effectively reduce restenosis but may increase late thrombosis and delayed restenosis. Persistent polymer could be responsible. Local delivery of paclitxel from a polymer-free Yinyi stent (Dalian Yinyi biomaterial research and development co.ltd) may prevent these complications.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Yinyi stent	subjects with Yinyi stent implantation

Timeline

• Start date: 2009-01-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2011-06-15
• Last updated: 2015-07-29

Locations

1 site across 1 country: China